Clinical Trials Browser

Small Cell Lung Carcinoma × Sorafenib × Clear all

NCT01159327 2015-11-11

Study of Sorafenib Maintenance in Patients With ED-SCLC After Response to Induction Chemotherapy

Phase 2 Terminated

Small Cell Lung Carcinoma

NCT00182689 2014-05-21

Sorafenib in Treating Patients With Extensive Stage Small Cell Lung Cancer

Phase 2 Completed

89 enrolled 12 charts

Small Cell Lung Carcinoma